薛定谔公司

US · SDGR #2667 按市值排名上市于 2020

22.60 -2.88 -11.30%

实时 - 追踪5344个代码 - 心跳于224秒前 · 2026-10-16 19:54

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了1家。
机构持股总比例下降了6.3个百分点。

机构持股

机构持股比例: 96.70% -6.35pp
机构数量: 281 -1
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流入——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund53.31%

Foundation21.58%

Hedge Fund16.02%

Public Company2.54%

Individual/Insider2.53%

Private Company1.99%

Government Pension Fund0.63%

Insurance Company0.43%

Family Office/Trust0.14%

Other0.82%

主要股东截至 2026-06-30

Bill & Melinda Gates Foundation Asset Trust 21.58% · 16.15M 股

BlackRock 14.07% · 10.52M 股

Rubric Capital Management LP 8.56% · 6.40M 股

Vanguard Portfolio Management, LLC 5.06% · 3.79M 股

UBS Asset Management 4.26% · 3.19M 股

Vanguard Capital Management, LLC 4.15% · 3.10M 股

Amova Asset Management 3.62% · 2.71M 股

State Street Global Advisors 3.07% · 2.30M 股

ARK Investment Management LLC 2.88% · 2.15M 股

AQR Capital Management 2.59% · 1.94M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 30次买入 · 17次卖出

姓名	职务	持股比例
Bill & Melinda Gates Foundation Asset Trust	--	21.58%
Richard Friesner	Co-Founder, Scientific Advisory Chairman and Director	1.88%
Ramy Farid	Chief Executive Officer	0.36%
Kenneth Lorton	Executive Vice President	0.05%
Arun Oberoi	Independent Director	0.02%
Rosana Kapeller-Libermann	Independent Director	0.02%
Gary Sender	Independent Director	0.02%
Gary Ginsberg	Independent Director	0.02%
Michael Lynton	Independent Chairperson	0.02%
Nancy Thornberry	Independent Director	0.02%
Jeffrey Chodakewitz	Independent Director	0.02%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-09-16	Karen Akinsanya	President of Research & Development Therapeutics	Derivative Exercise and Sale	-31,599	$4.34–30.00
2026-07-15	Richie Jain	Senior Vice President of Strategic Finance & Business Development	Automatic Disposition	-875	$15.60
2026-06-30	Mannix Aklian	--	Intent to Sell (Form 144)	-1,136	$16.68
2026-06-25	Richard Friesner	Co-Founder, Scientific Advisory Chairman and Director	Other Acquisition	+679,373	--
2026-06-25	Richard Friesner	Co-Founder, Scientific Advisory Chairman and Director	Other Disposition	-679,373	--
2026-06-21	Michael Lynton	Independent Chairperson	Other Acquisition	+8,141	--
2026-06-21	Michael Lynton	Independent Chairperson	Other Derivative Acquisition	+13,313	$15.23
2026-06-21	Gary Ginsberg	Independent Director	Other Acquisition	+8,141	--
2026-06-21	Gary Ginsberg	Independent Director	Other Derivative Acquisition	+13,313	$15.23
2026-06-21	Gary Sender	Independent Director	Other Acquisition	+8,141	--
2026-06-21	Gary Sender	Independent Director	Other Derivative Acquisition	+13,313	$15.23
2026-06-21	Arun Oberoi	Independent Director	Other Acquisition	+8,141	--
2026-06-21	Arun Oberoi	Independent Director	Other Derivative Acquisition	+13,313	$15.23
2026-06-21	Rosana Kapeller-Libermann	Independent Director	Other Acquisition	+8,141	--
2026-06-21	Rosana Kapeller-Libermann	Independent Director	Other Derivative Acquisition	+13,313	$15.23
2026-06-21	Bridget van Kralingen	Director	Other Acquisition	+8,141	--
2026-06-21	Bridget van Kralingen	Director	Other Derivative Acquisition	+13,313	$15.23
2026-06-21	Richard Friesner	Co-Founder, Scientific Advisory Chairman and Director	Other Acquisition	+8,141	--
2026-06-21	Richard Friesner	Co-Founder, Scientific Advisory Chairman and Director	Other Derivative Acquisition	+13,313	$15.23
2026-06-21	Nancy Thornberry	Independent Director	Other Acquisition	+8,141	--

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:54:49 · 仅供参考，不构成投资建议，也未考虑您的具体情况。